At Cancer Patients Europe, we are dedicated to reducing the burden of cancer and amplifying the voices of cancer patients and survivors across Europe. Our mission is to serve as a united voice for the cancer community, advocating for their needs and rights at every stage of their journey. Through strategic priorities encompassing multiple focus areas, ranging from prevention to precision oncology, and rare cancers, we strive to realise our vision of a future where the impact of cancer is significantly diminished.
Through these focus areas, we fulfil our mission of representing and empowering cancer patients, their care givers, and survivors while working towards our vision of reducing the burden of cancer for all.
Learn more about our current projects as we continue to push for a brighter future for the cancer community.
Why it matters DynamiCity aims to make cities healthier, cleaner and more people-friendly by encouraging more walking, cycling and other forms of active mobility.… Read More
Why it matters Mature T-cell leukemias and lymphomas (MaTCL) are rare blood cancers with limited treatment options and poor survival rates, as current therapies… Read More
Why it matters The project aims to address critical challenges in the treatment of triple-negative breast cancer (TNBC), a notably difficult-to-treat subtype with high… Read More
Why it matters PERIFORMANCE aims to improve cancer research by involving everyone affected by or working in cancer care, including patients, carers, doctors, researchers,… Read More
EOSC4Cancer boosts EU-wide cancer research by integrating clinical, imaging, and genomic data, with CPE ensuring patient engagement and relevance. Read More
OncoProTools enhances cancer care with protease-targeting strategies and patient-focused training to improve diagnostics, therapies, and communication.
Read More
CPE raises awareness of ESR1 mutations in metastatic breast cancer, promoting liquid biopsy and personalized care through EU-led advocacy and research. Read More
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare blood cancer originating from precursor dendritic cells. This form of rare cancer has often gone underdiagnosed due to misclassification and lack of knowledge. To address this, CPE aims to increase awareness amongst society to promote positive outcomes. Read More
QUALITOP is an EU-funded project that aims to improve the well-being and quality of life of cancer patients undergoing immunotherapy. Cancer Patients Europe plays a vital role by leading communication and dissemination efforts, ensuring the project’s findings reach patients, healthcare professionals, and policymakers. Read More
Launched in 2022, myC (my Cancer my Concern) aims to raise awareness of the benefits and values of genomic testing in cancer, educate patients and stakeholders, and improve accessibility to genomic testing across Europe. Read More
CPE is a consortium member of the EU-funded project: THERMOBREAST. It aims to deliver an innovative alternative to mammography, a non-contact breast cancer screening modality using advanced AI and thermal imaging technology. Read More
CPE is a collaborating partner of the INTERCEPTOR project together with IARC, OECI, and EORTC. This is a project funded within the COST ACTION programme with 125 participants. It aims to develop personalised strategies for oral potentially malignant disorders. We lead communication efforts to ensure these innovations benefit all EU citizens. Read More